Cargando…
Strongyloides hyperinfection syndrome precipitated by immunosuppressive therapy for rheumatoid arthritis and COVID-19 pneumonia
The COVID-19 pandemic has posed clinical and public health challenges worldwide. The use of corticosteroids has become an evidence-based practice to reduce the hyperinflammatory process involved in severe COVID-19 disease. However, this can result in the reactivation of parasitic infestations, even...
Autores principales: | Hamze, Hasan, Tai, Teresa, Harris, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552379/ https://www.ncbi.nlm.nih.gov/pubmed/37794447 http://dx.doi.org/10.1186/s40794-023-00201-0 |
Ejemplares similares
-
Immunosuppression with Antitumour Necrosis Factor Therapy Leading to Strongyloides Hyperinfection Syndrome
por: Khaliq, Muhammad Farhan, et al.
Publicado: (2018) -
A Case of Hyperinfection with Strongyloides Stercoralis in an Immunosuppressed Patient
por: Kim, Yu Kyung, et al.
Publicado: (1989) -
Strongyloides stercoralis Hyperinfection Syndrome in Pregnancy
por: Akers, Allison N, et al.
Publicado: (2023) -
Loeffler's Syndrome Secondary to Hyperinfection by Strongyloides stercoralis Associated with Methotrexate in a Patient with Rheumatoid Arthritis
por: Al Hadidi, Moayad, et al.
Publicado: (2018) -
Fatal Strongyloides Hyperinfection Syndrome in an Immunocompromised Patient
por: Pochineni, Vaishnavi, et al.
Publicado: (2015)